We are live on
!
Find out more
Aberdeen Group Portfolio holdings
AUM
$71.2B
Turnover
9.3%
1-Year Est. Return
41.74%
This Fund
S&P 500
This Quarter
Est. Return
+15.18%
1 Year Est. Return
+41.74%
3 Year Est. Return
+120.47%
5 Year Est. Return
+149.18%
10 Year Est. Return
–
AUM
$46.2B
AUM Growth
+$4.02B
(+9.6%)
Cap. Flow
-$2.06B
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
19.65%
Holding
934
New
52
Increased
488
Reduced
320
Closed
33
Avg Time Held
1.3
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$191M |
| 2 |
Microsoft
MSFT
|
+$169M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$162M |
| 4 |
Netflix
NFLX
|
+$126M |
| 5 |
Philip Morris
PM
|
+$87.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$231M |
| 2 |
Banco Bradesco
BBD
|
+$182M |
| 3 |
Amdocs
DOX
|
+$175M |
| 4 |
Oracle
ORCL
|
+$156M |
| 5 |
Chevron
CVX
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.31% |
| 2 | Technology | 14.86% |
| 3 | Consumer Discretionary | 13.47% |
| 4 | Healthcare | 10.93% |
| 5 | Communication Services | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
551
Conagra Brands
CAG
$6.91B
| $7.9M | 0.02% |
284,855
+85,396
| +43% | +$1.96M |
2017 Q3
6 quarters
|
|
552
Idexx Laboratories
IDXX
$44.1B
| $7.75M | 0.02% |
34,658
+9,732
| +39% | +$2.01M |
2017 Q3
6 quarters
|
|
553
Vulcan Materials
VMC
$33.4B
| $7.7M | 0.02% |
65,043
+17,488
| +37% | +$1.89M |
2017 Q3
6 quarters
|
|
554
EPAM Systems
EPAM
$6.3B
| $7.63M | 0.02% |
45,103
-10,612
| -19% | -$1.59M |
2017 Q3
6 quarters
|
|
555
Orion
OEC
$302M
| $7.6M | 0.02% |
400,000
| – | – |
2018 Q2
3 quarters
|
|
556
Arthur J. Gallagher & Co
AJG
$65.3B
| $7.49M | 0.02% |
95,933
+23,775
| +33% | +$1.83M |
2017 Q3
6 quarters
|
|
557
McCormick & Company Non-Voting
MKC
$12.5B
| $7.42M | 0.02% |
98,472
+35,296
| +56% | +$2.38M |
2017 Q3
6 quarters
|
|
558
ManpowerGroup
MAN
$1.93B
| $7.35M | 0.02% |
88,875
+6,841
| +8% | +$539K |
2017 Q3
6 quarters
|
|
559
Cadence Design Systems
CDNS
$88B
| $7.27M | 0.02% |
114,410
+39,501
| +53% | +$2.09M |
2017 Q3
6 quarters
|
|
560
Mettler-Toledo International
MTD
$32.5B
| $7.22M | 0.02% |
9,988
+3,516
| +54% | +$2.29M |
2017 Q3
6 quarters
|
|
561
Nektar Therapeutics
NKTR
$1.22B
| $7.2M | 0.02% |
14,275
-686
| -5% | -$407K |
2017 Q3
6 quarters
|
|
562
Quest Diagnostics
DGX
$25.9B
| $7.18M | 0.02% |
79,841
+20,435
| +34% | +$1.77M |
2017 Q3
6 quarters
|
|
563
Lincoln National
LNC
$7.63B
| $7.08M | 0.02% |
120,658
+35,095
| +41% | +$2.08M |
2017 Q3
6 quarters
|
|
564
SEI Investments
SEIC
$12.5B
| $6.94M | 0.02% |
132,831
+80,174
| +152% | +$4.01M |
2017 Q4
5 quarters
|
|
565
Warrior Met Coal
HCC
$4.75B
| $6.93M | 0.02% |
+228,104
| New | +$6.24M |
2019 Q1
0 quarters
|
|
566
D.R. Horton
DHI
$39B
| $6.92M | 0.02% |
167,259
+53,551
| +47% | +$2.1M |
2017 Q3
6 quarters
|
|
567
Synopsys
SNPS
$87.1B
| $6.91M | 0.02% |
60,012
+19,916
| +50% | +$1.97M |
2017 Q3
6 quarters
|
|
568
C.H. Robinson
CHRW
$16.3B
| $6.89M | 0.01% |
79,131
+18,666
| +31% | +$1.64M |
2017 Q3
6 quarters
|
|
569
MSCI
MSCI
$41.4B
| $6.88M | 0.01% |
34,617
+11,815
| +52% | +$2.06M |
2018 Q1
4 quarters
|
|
570
Everest Group
EG
$14.9B
| $6.76M | 0.01% |
31,299
-50,853
| -62% | -$11.1M |
2017 Q3
6 quarters
|
|
571
T-Mobile US
TMUS
$171B
| $6.76M | 0.01% |
97,771
+21,319
| +28% | +$1.49M |
2017 Q3
6 quarters
|
|
572
Arista Networks
ANET
$223B
| $6.73M | 0.01% |
342,544
+121,872
| +55% | +$1.93M |
2018 Q2
3 quarters
|
|
|
CIT
573
DELISTED
CIT Group Inc.
CIT
| $6.69M | 0.01% |
139,520
-14,115
| -9% | -$664K |
2017 Q3
6 quarters
|
|
|
WCG
574
DELISTED
Wellcare Health Plans, Inc.
WCG
| $6.61M | 0.01% |
24,513
+5,722
| +30% | +$1.48M |
2018 Q1
4 quarters
|
|
575
Skyworks Solutions
SWKS
$18.7B
| $6.6M | 0.01% |
80,048
+24,925
| +45% | +$1.92M |
2017 Q3
6 quarters
|
|
Similar funds
Aberdeen Group's Q1 2019 Portfolio in Review
As of Q1 2019, Aberdeen Group held 934 positions worth $46.2B, up 9.6% from $42.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Aberdeen Group withdrew a net $2.06B in Q1 2019, closing 33 positions and reducing 320 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class A, an estimated $36M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Aberdeen Group opened a new position in Linde worth $203M.
- Aberdeen Group's largest Q1 2019 buy was Linde: 1,152,668 shares worth $203M.
- Aberdeen Group added most to Microsoft in Q1 2019, an estimated $169M increase.
- Aberdeen Group's biggest Q1 2019 reduction was Pfizer, cutting an estimated $231M.
- Aberdeen Group fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $36M.
- Aberdeen Group's ten largest holdings make up 20% of its $46.2B portfolio in Q1 2019.
- Aberdeen Group opened 52 new positions and closed 33 in Q1 2019.
- Aberdeen Group's portfolio value rose 9.6% quarter-over-quarter to $46.2B.
Based on Aberdeen Group's 13F filing for Q1 2019, filed 14 May 2019.